# Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

> **NCT03164291** · PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center at Tyler** · enrollment: 170 (actual)

## Conditions studied

- Nontuberculous Mycobacterial Infections

## Interventions

- **DRUG:** Rifabutin

## Key facts

- **NCT ID:** NCT03164291
- **Lead sponsor:** The University of Texas Health Science Center at Tyler
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1984-06
- **Primary completion:** 2006-09
- **Final completion:** 2017-05-18
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03164291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03164291, "Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03164291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*